| The reason of the increase (decrease) in the sales/ revenues during the current quarter compared to the same quarter of the last year is | The Company's quarterly revenues exceeded SAR 1 billion for the first time. Revenues in the second quarter of 2025 increased by 38.8% to SAR 1,062 million, compared to SAR 765 million for the same quarter of the previous year, an increase of SAR 297 million. This was a result of the increased operational capacity and strategic expansions undertaken by the group, both in existing and acquired medical facilities. This contributed to the continued growth in the number of visitors to the group's hospitals. The acquisition of Al Salam Medical Services Company, owner of Dallah Hospital Al-Khobar, and Al Ahsa Medical Services Company, owner of Dallah Hospital Al-Ahsa, on March 23, 2025, had a positive impact on the increase in revenues. Total revenue for the two hospitals in the current quarter recorded approximately SAR 176 million, amounting to about 59% of the total revenue increase. Dallah Hospital Al-Khobar and Dallah Hospital Al-Ahsa saw a surge in revenue under Dallah Health's management. Their revenues rose by approximately SAR 73 million, a 72% increase in the current quarter compared to the same quarter of the previous year (note that revenues for the same quarter of the previous year for the two hospitals are not included in Dallah Health's revenues as they precede the acquisition date). The acquisition of the two hospitals contributed a 37% increase in the group's bed capacity with the addition of 424 beds (274 beds in Dallah Hospital Al-Ahsa and 150 beds in operation in Dallah Hospital Al-Khobar). This percentage will increase to 65% when Dallah Hospital Al-Khobar is fully operational with a capacity of 475 beds. This will bring the group's bed capacity to more than 1,900 beds, and a total of 2,560 beds when beds in its associate companies are accounted for. The deal is expected to increase the group's revenues by approximately SAR 500 million during the entire year 2025 (starting from the acquisition date on March 23, 2025), and this growth is expected to maintain a strong momentum in the following years with the increase in the operating rates of the two hospitals, especially Dallah Hospital Al-Khobar. The group's existing medical facilities prior to the acquisition also achieved 15.8% growth in revenue for the second quarter of 2025 compared to the same quarter of the previous year, amounting to SAR 121 million. |
| The reason of the increase (decrease) in the net profit during the current quarter compared to the same quarter of the last year is | Net profit attributable to shareholders for the second quarter of 2025 increased by 11.1% to SAR 124 million, compared to SAR 112 million for the same quarter of the previous year, an increase of SAR 12 million. This resulted in an increase in earnings per share for the current quarter to SAR 1.23 per share, compared to SAR 1.15 per share for the same quarter of the previous year. This increase is due to: - Increased revenues for the second quarter of 2025, which led to a 26.3% increase in gross profit to SAR 376 million, compared to SAR 298 million in the same quarter of the previous year, an increase of SAR 78 million. Operating profit for the second quarter of 2025 also improved by 9.9%, reaching SAR 155 million, compared to SAR 141 million in the same quarter of the previous year. The Company also concluded its zakat file review until 2023, resulting in a reversal of provisions of SAR 12.5 million. - Following the acquisition of Dallah Hospital Al-Khobar and under Dallah Health's management, the hospital's net losses were reduced by 61% to SAR 18 million during the current quarter compared to the same quarter of the previous year. The reduction of losses is attributed to a significant increase in visits and enhanced efficiency of the hospital, which is still in its early stages of operation. (It should be noted that Dallah Hospital Al-Khobar's losses for the same quarter of the previous year are not included in Dallah Healthcare's profits as they precede the acquisition date.) Net profit before interest, depreciation, amortization, and zakat increased by 23.4% in the second quarter of 2025 to SAR 229 million, compared to SAR 186 million in the same quarter of the previous year, an increase of SAR 43 million. |
| The reason of the increase (decrease) in the sales/ revenues during the current quarter compared to the previous one is | The Company's quarterly revenues exceeded SAR 1 billion for the first time. Revenues in the second quarter of 2025 increased by 27.6% to SAR 1,062 million, compared to SAR 833 million in the previous quarter, an increase of SAR 230 million. This was a result of the group's increased operational capacity and strategic expansions, both in existing and acquired medical facilities. This contributed to the continued growth in the number of visitors to the group's hospitals. The acquisition of Al Salam Medical Services Company, owner of Dallah Hospital Al-Khobar, and Al Ahsa Medical Services Company, owner of Dallah Hospital Al-Ahsa, on March 23, 2025, had a positive impact on the increase in revenues. Total revenues for the two hospitals in the current quarter amounted to approximately SAR 176 million (Dallah Healthcare recorded revenues from the two hospitals in the previous quarter of SAR 13 million due to the completion of the acquisition procedures at the end of the previous quarter). Dallah Hospital Al-Khobar and Dallah Hospital Al-Ahsa saw a surge in revenue under Dallah Health's management. Their revenues increased by approximately SAR 53 million, a 43% increase in the current quarter compared to the previous quarter. (It should be noted that Dallah Healthcare recorded SAR 13 million in revenue for both hospitals in the previous quarter, due to the completion of the acquisition procedures at the end of the previous quarter.) The acquisition of the two hospitals contributed a 37% increase in the group's bed capacity, adding 424 beds (274 in Dallah Al-Ahsa Hospital and 150 in Dallah Al-Khobar Hospital). This percentage will increase to 65% when Dallah Al-Khobar Hospital is fully operational, with a capacity of 475 beds. This will bring the group's bed capacity to more than 1,900 beds, and a total of 2,560 beds when beds in its associate companies are accounted for. The deal is expected to increase the group's revenues by approximately SAR 500 million throughout 2025. This growth is expected to maintain strong momentum in the following years, with increased operating rates at the two hospitals, particularly Dallah Hospital Al-Khobar. The group's existing medical facilities prior to the acquisition also achieved revenue growth for the second quarter of 2025, compared to the previous quarter, with an increase of SAR 68 million, representing an increase of 8.2%. |
| The reason of the increase (decrease) in the net profit (loss) during the current quarter compared to the previous one is | Net profit attributable to shareholders for the second quarter of 2025 decreased by 20% to SAR 124 million, compared to SAR 156 million in the previous quarter, a decrease of SAR 31 million. This resulted in a decrease in earnings per share for the current quarter, reaching SAR 1.23 per share, compared to SAR 1.59 per share in the previous quarter. This is due to: - A non-recurring event in the first quarter of 2025, where the Company entered into a real estate fund with a 33.33% stake through an in-kind contribution of land, resulting in a gain of SAR 51 million during the first quarter. It is worth noting that the fund raised SAR 613 million in capital and aims to develop a mixed-use project comprising commercial, office, hotel, and healthcare space in the Al Nakheel neighborhood on King Fahd Road in Riyadh. The acquisition of Dallah Hospital Al-Khobar resulted in a net loss of SAR 18 million, as the hospital is still in its early stages of operation. Under Dallah Health's management, Dallah Hospital Al-Khobar saw a sharp increase in visits and a significant decline in losses, which decreased by 39% compared to the previous quarter. (It should be noted that Dallah Healthcare recorded its share of the hospital's losses in the previous quarter, amounting to SAR 4 million, due to the completion of the acquisition procedures at the end of the previous quarter.) Excluding the aforementioned non-recurring event, the Company would have achieved a 19.3% increase in net profit attributable to shareholders in the second quarter of 2025 compared to the previous quarter. As a result of the aforementioned non-recurring event in the previous quarter, net profit before interest, depreciation, amortization, and zakat decreased by 1% in the second quarter of 2025 to SAR 229 million, compared to SAR 232 million in the previous quarter, a decrease of SAR 3 million. If the non-recurring event mentioned above was excluded, the Company would have achieved a 27% increase in net profit before debt, amortization, depreciation and zakat costs in the current quarter compared to the previous quarter. |
| The reason of the increase (decrease) in the sales/ revenues during the current period compared to the same period of the last year is | Revenues for the six-month period of 2025 increased by 22.3% to SAR 1,895 million, compared to SAR 1,549 million for the same period last year, an increase of SAR 346 million. This was due to the record revenues achieved in the current quarter due to increased operational capacity and strategic expansions undertaken by the group, both in existing and acquired medical facilities. This contributed to the continued growth in the number of visitors to the group's hospitals. The acquisition of Al Salam Medical Services Company, owner of Dallah Hospital Al-Khobar, and Al Ahsa Medical Services Company, owner of Dallah Hospital Al-Ahsa, on March 23, 2025, had a positive impact on the increase in revenues, with the total revenues of the two hospitals for the current period amounting to approximately SAR 189 million. Dallah Hospital Al-Khobar and Dallah Hospital Al-Ahsa saw a surge in revenue under Dallah Health's management. Their revenues increased by approximately SAR 101 million, a 52% increase, during the current period compared to the same period last year (note that the hospitals' revenues for the same period last year are not included in Dallah Healthcare's revenues as they precede the acquisition date). The acquisition of the two hospitals contributed a 37% increase in the group's bed capacity, with the addition of 424 beds (274 beds in Dallah Al-Ahsa Hospital and 150 beds in operation in Dallah Al-Khobar Hospital). This percentage will increase to 65% when Dallah Al-Khobar Hospital is fully operational with a capacity of 475 beds. This will bring the group's bed capacity to more than 1,900 beds, and a total of 2,560 beds when beds in associate companies are accounted for. The deal is expected to increase the group's revenues by approximately SAR 500 million throughout 2025 (starting from the acquisition date of March 23, 2025). This growth is expected to continue at high rates in the following years, with increased operating rates at the two hospitals, particularly Dallah Hospital Al-Khobar. The group's existing medical facilities prior to the acquisition also achieved revenue growth of SAR 157 million, a 10.1% increase over the same period last year. |
| The reason of the increase (decrease) in the net profit during the current period compared to the same period of the last year is | Net profit attributable to shareholders for the six-month period of 2025 increased by 21.1% to SAR 280 million, compared to SAR 231 million for the same period last year, an increase of SAR 49 million. This resulted in an increase in earnings per share for the current period to SAR 2.81 per share, compared to SAR 2.37 per share for the same period last year. This is due to: - Increased revenues for the period of 2025, which led to a 13.9% increase in gross profit to SAR 673 million, compared to SAR 591 million for the same period last year, an increase of SAR 82 million. Operating profit for the period of 2025 also improved by 14.7%, reaching SAR 333 million, compared to SAR 290 million for the same period last year. The Company also concluded its zakat file review until 2023, resulting in a reversal of provisions of SAR 12.5 million. - Following the acquisition of Dallah Hospital Al-Khobar and under Dallah Health's management, the hospital's net losses were reduced by 49% to SAR 23 million during the current period compared to the same period in 2024. The reduction of losses is attributed to a significant increase in visits and enhanced efficiency of the hospital, which is still in its early stages of operation. (It should be noted that Dallah Hospital Al-Khobar's losses for the same period last year are not included in Dallah Health's profits as they precede the acquisition date.) Net profit before interest, depreciation, amortization, and zakat for the period rose by 21.3% to SAR 462 million, compared to SAR 381 million in the same period last year, an increase of SAR 81 million. |
| Statement of the type of external auditor's report | Unmodified conclusion |
| Comment mentioned in the external auditor’s report, mentioned in any of the following paragraphs (other matter, conservation, notice, disclaimer of opinion, or adverse opinion) | N/A |
| Reclassification of Comparison Items | N/A |
| Additional Information | - |
| Attached Documents |  |